| Identification | |
| Name: | 2-Naphthaleneaceticacid, 6-methoxy-a-methyl-,4-(nitrooxy)butyl ester, (aS)- |
| Synonyms: | 2-Naphthaleneaceticacid, 6-methoxy-a-methyl-,4-(nitrooxy)butyl ester, (S)-; (S)-2-(6-Methoxy-2-naphthyl)propanoic acid4-nitrooxybutyl ester; AR-P 900758XX; AZD 3582; HCT 3012; Naproxcinod;Nitronaproxen |
| CAS: | 163133-43-5 |
| Molecular Formula: | C18H21 N O6 |
| Molecular Weight: | 347.36 |
| InChI: | InChI=1S/C18H21NO6/c1-13(18(20)24-9-3-4-10-25-19(21)22)14-5-6-16-12-17(23-2)8-7-15(16)11-14/h5-8,11-13H,3-4,9-10H2,1-2H3 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.213 |
| Specification: |
?Naproxcinod (CAS NO.163133-43-5) is also named as?Naproxcinod [USAN]?; (S)-2-(6-Methoxy-2-naphthyl)propanoic acid 4-nitrooxybutyl ester ; 4-(Nitrooxy)butyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate ; AR-P900758XX ; AZD 3582 ; HCT 3012 ; Naproxcinod ; Nitronaproxen ; UNII-V24GR4LI3I ; 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, 4-(nitrooxy)butyl ester, (S)- ; 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, 4-(nitrooxy)butyl ester, (alphaS)- .?Naproxcinod (CAS NO.163133-43-5) is a non-steroidal antiinflammatory drug (NSAID) developed by the French pharmaceutical company NicOx. |
| Safety Data | |
 |
|
